Funding for this research was provided by:
GlaxoSmithKline Biologicals SA (GSK study identifier: HO-16-17407)
Text and Data Mining valid from 2019-12-01
Received: 17 July 2019
Accepted: 29 November 2019
First Online: 17 December 2019
Ethics approval and consent to participate
: Not applicable.
: FK was employee of the GSK group of companies at the time of the study and holds shares in the GSK group of companies. JJ and MS received an unrestricted grant for the conduct of this study and the preparation of the manuscript by the GSK group of companies. In addition, JJ received a grant from the GSK group of companies for presenting the study results at a national health economics conference. JJ and MS have no further conflict that would be directly relevant to the content of the article.